Skip to main content
. 2021 Jul 6;12(14):1377–1387. doi: 10.18632/oncotarget.28000

Table 3. Cell cycle evaluation after 48-hour treatments.

% G0/G1 S G2/M
NT 47, 6 ± 2, 7 20, 5 ± 4, 8 28, 5 ± 4, 4
ELT 30, 3 ± 5, 1* 29, 5 ± 0, 4* 26 ± 2, 0
DFX 36, 75 ± 2, 0* 27, 3 ± 5, 5* 31 ± 4, 5*
CYT 32 ± 6, 5* 48, 7 ± 7, 4* 16, 1 ± 8, 6*
ELT + DFX 33, 9 ± 6, 5* 29, 1 ± 8, 1* 33, 3 ± 3, 4*
ELT + CYT 71, 9 ± 12, 6* 15, 6 ± 1, 2* 10, 7 ± 1, 5*
DFX + CYT 29, 5 ± 0, 8* 54, 2 ± 7, 9* 14, 1 ± 1, 7*

Percentage of THP-1 cell cells at different phases of the cell cycle after 48 h of exposure to ELT, DFX and Cytarabine, alone and in combination. Cells were harvested, fixed, incubated with Muse Cell Cycle reagents and analyzed on “MUSE Cell Analyzer”. The results are presented as the mean percentage ± SD of three independent experiments and were analyzed by t-test. * indicates p ≤ 0.05 compared to non-treated sample (NT).

* p ≤ 0,05.